Huynh-Hoa Bui

USPTO Granted Patents = 25 (Patent Applications = 44)

CIPO Patents = 2 (Patent Applications = 25)

EPO Patents = 9 (Patent Applications = 53)

Average Co-Inventor Count = 2.6

ph-index = 4

Forward Citations = 33(Granted Patents)

Location History:

Carlsbad, CA (US) (2023)
San Diego, CA (US) (2017 - 2024)

Company Filing History:

21 out of 271

Ionis Pharmaceuticals, Inc.

Ludwig Institute for Cancer Research Limited

Lonis Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 2017-2025

Loading Chart...

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12384814 - Compounds and methods for reducing app expression (2025-08-12),

2. 12281305 - Compounds and methods for reducing prion expression (2025-04-21),

3. 12091662 - Compositions for modulating tau expression (2024-09-17),

4. 12042510 - Modulators of IRF4 expression (2024-07-23),

5. 12018261 - Compounds and methods for modulating factor XII (2024-06-25),

6. 11840689 - Method of treating fatty liver disease (2023-12-12),

7. 11840686 - Modulation of prekallikrein (PKK) expression (2023-12-12),

8. 11833168 - Compounds and methods for increasing STMN2 expression (2023-12-05),

9. 11781143 - Modulators of PNPLA3 expression (2023-10-10),

10. 11633483 - Modulators of PCSK9 expression (2023-04-25),

11. 11591595 - Compositions for modulating Tau expression (2023-02-28),

12. 11312964 - Compositions and methods for modulating growth hormone receptor expression (2022-04-26),

13. 11241451 - Modulators of IRF4 expression (2022-02-08),

14. 11214803 - Modulators of YAP1 expression (2022-01-04),

15. 11053500 - Modulation of prekallikrein (PKK) expression (2021-07-06),

Title: Innovations and Contributions of Huynh-Hoa Bui in Biotechnology

Introduction

Huynh-Hoa Bui is a prominent inventor based in San Diego, California, known for his significant contributions to the field of biotechnology. With 23 patents to his name, his innovative work focuses on developing therapies that target specific molecular mechanisms involved in diseases, particularly those related to tau pathologies and cancer.

Latest Patents

Among his latest patents, one notable invention is related to compositions for modulating tau expression. This patent discloses antisense compounds and methods aimed at decreasing Tau mRNA and protein expression. The utility of these compounds and methods is particularly relevant in treating, preventing, or ameliorating tau-associated diseases, disorders, and conditions. Another significant patent involves modulators of IRF4 expression. This invention provides methods, compounds, and compositions that inhibit IRF4 expression, offering promising avenues for the treatment of cancers associated with this factor.

Career Highlights

Huynh-Hoa Bui has an extensive career in the biotechnology sector, having worked with well-respected organizations such as Ionis Pharmaceuticals, Inc. and Biogen MA Inc. His work at these companies has contributed to the advancement of therapeutic options in the fields of neurology and oncology.

Collaborations

Throughout his career, Bui has collaborated with esteemed colleagues, including Susan M. Freier and Eric E. Swayze. These collaborations have fostered the exchange of ideas and innovations, ultimately leading to breakthroughs in their respective research areas.

Conclusion

Huynh-Hoa Bui's dedication to innovation in biotechnology is evidenced by his numerous patents and collaborations. His work not only exemplifies the spirit of scientific inquiry but also holds the potential for significant advancements in the treatment of various diseases, underscoring his status as a crucial figure in modern biomedicine.

This text is generated by artificial intelligence and may not be accurate.